[Pell Bio-Medical] Announcement of Change in Head of R&D
Pell Bio-Medical announced that Deputy Head of R&D Lin Wei-Chi will resign for personal career planning, effective May 20, 2026. The role of Head of R&D will be temporarily assumed by Lin Ren-Jie, the current Director of the R&D Department.
📋 Article Processing Timeline
- 📰 Published: May 20, 2026 at 09:00
- 🔍 Collected: May 21, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 21, 2026 at 09:33 (1h 33m after Collected)
1. Type of personnel change: Head of R&D
2. Date of change: 2026/05/20
3. Name, title, and brief resume of the former officer: Lin Wei-Chi / Deputy Head of R&D of the company
4. Name, title, and brief resume of the new officer: Lin Ren-Jie (Acting) / Director of the R&D Department of the company
5. Nature of the change: Resignation
6. Reason for the change: Personal career planning
7. Effective date: 2026/05/20
8. Other matters to be specified: None
2. Date of change: 2026/05/20
3. Name, title, and brief resume of the former officer: Lin Wei-Chi / Deputy Head of R&D of the company
4. Name, title, and brief resume of the new officer: Lin Ren-Jie (Acting) / Director of the R&D Department of the company
5. Nature of the change: Resignation
6. Reason for the change: Personal career planning
7. Effective date: 2026/05/20
8. Other matters to be specified: None